Eli Lilly and Company
Anti-Alpha-Synuclein Antibodies and Uses Thereof
Last updated:
Abstract:
The present invention relates to anti-alpha-synuclein antibodies, and uses thereof for treating diseases such as Parkinson's disease.
Status:
Application
Type:
Utility
Filling date:
9 Dec 2019
Issue date:
17 Feb 2022